BARCLAYS PLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 1 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$277
+130.8%
148,016
+206.6%
0.00%
Q2 2023$120
-72.2%
48,272
-80.4%
0.00%
Q1 2023$432
+632.2%
246,464
+1678.4%
0.00%
Q4 2022$59
-97.0%
13,859
+563.4%
0.00%
Q3 2022$2,000
+100.0%
2,089
+85.2%
0.00%
Q2 2022$1,000
-90.9%
1,128
-74.1%
0.00%
Q1 2022$11,0004,3610.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders